Coloplast AS 

$6.45
320
+$0.07+1.1% Friday 19:50

Statistics

Day High
6.53
Day Low
6.42
52W High
10.03
52W Low
5.64
Volume
25,334
Avg. Volume
472,716
Mkt Cap
1.34B
P/E Ratio
43.71
Dividend Yield
5.58%
Dividend
0.36

Upcoming

Dividends

5.58%Dividend Yield
Jun 26
$0.08
Dec 25
$0.28
May 25
$0.08
Dec 24
$0.24
May 24
$0.07
10Y Growth
6.2%
5Y Growth
4.11%
3Y Growth
5.82%
1Y Growth
0.71%

Earnings

18AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.61
0.74
0.86
0.99
Expected EPS
0.9417769836
Actual EPS
N/A

Financials

12.98%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
4.17BRevenue
541.93MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CLPBY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Show more...
CEO
Mr. Anders Lonning-Skovgaard
Employees
16741
Country
Denmark
ISIN
US19624Y2000

Listings

0 Comments

Share your thoughts

FAQ

What is Coloplast AS stock price today?
The current price of CLPBY is $6.45 USD — it has increased by +1.1% in the past 24 hours. Watch Coloplast AS stock price performance more closely on the chart.
What is Coloplast AS stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Coloplast AS stocks are traded under the ticker CLPBY.
Is Coloplast AS stock price growing?
CLPBY stock has risen by +5.39% compared to the previous week, the month change is a +12.17% rise, over the last year Coloplast AS has showed a -31.38% decrease.
What is Coloplast AS market cap?
Today Coloplast AS has the market capitalization of 1.34B
When is the next Coloplast AS earnings date?
Coloplast AS is going to release the next earnings report on August 18, 2026.
What were Coloplast AS earnings last quarter?
CLPBY earnings for the last quarter are 0.95 USD per share, whereas the estimation was 0.91 USD resulting in a +4.29% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Coloplast AS revenue for the last year?
Coloplast AS revenue for the last year amounts to 4.17B USD.
What is Coloplast AS net income for the last year?
CLPBY net income for the last year is 541.93M USD.
Does Coloplast AS pay dividends?
Yes, CLPBY dividends are paid semi-annual. The last dividend per share was 0.08 USD. As of today, Dividend Yield (FWD)% is 5.58%.
How many employees does Coloplast AS have?
As of July 18, 2026, the company has 16,741 employees.
In which sector is Coloplast AS located?
Coloplast AS operates in the Health & Wellness sector.
When did Coloplast AS complete a stock split?
The last stock split for Coloplast AS was on December 16, 2004 with a ratio of 2:1.
Where is Coloplast AS headquartered?
Coloplast AS is headquartered in Humlebæk, Denmark.